Eli Lilly CEO David Ricks gifts 23,538 shares
The CEO's disclosed positions also include common shares held through two GRATs, a trust, a SLAT and a 401(k).
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Eli Lilly & Co. President, Chair, and CEO David A. Ricks reported a gift disposition of 23,538 common shares on November 3, 2026; his direct holdings afterward were 555,278 shares. No Rule 10b5-1 plan is reported. The November 3 holdings also list 4,574 shares in his 2025 GRAT, 49,127 in his 2022 GRAT, 300 in a trust, 68,656 in his SLAT, and 7,338 in a 401(k). Ricks disclaims beneficial ownership of securities in the GRAT, trust, and SLAT entries except to the extent of his pecuniary interest.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock F1 | 23,538 | $0.00 | $0.00 |
| Holding | Common Stock F2, F3 | -- | -- | -- |
| Holding | Common Stock F2, F4 | -- | -- | -- |
| Holding | Common Stock F2 | -- | -- | -- |
| Holding | Common Stock F2 | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
Footnotes (4)
- F1. The amount reported includes (i) 4,990 shares of Eli Lilly and Company common stock transferred to the reporting person on May 14, 2026 as an annuity payment from the 2022 GRAT and (ii) 2,111 shares of Eli Lilly and Company common stock transferred to the reporting person on September 18, 2026 as an annuity payment from the 2025 GRAT, each a Grantor Retained Annuity Trust of which the reporting person is the trustee and each paid in accordance with its terms.
- F2. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- F3. On September 18, 2026, 2,111 shares of Eli Lilly and Company common stock were transferred to the reporting person as an annuity payment in accordance with the terms of the Grantor Retained Annuity Trust, of which the reporting person is the trustee.
- F4. On May 14, 2026, 4,990 shares of Eli Lilly and Company common stock were transferred to the reporting person as an annuity payment in accordance with the terms of the Grantor Retained Annuity Trust, of which the reporting person is the trustee.
Key Figures
Key Terms
Grantor Retained Annuity Trust financial
annuity payment financial
pecuniary interest financial
beneficial ownership financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.